Co-Authors
This is a "connection" page, showing publications co-authored by Jorge Salluh and Pedro Povoa.
Connection Strength
3.726
-
When should we use corticosteroids in severe community-acquired pneumonia? Curr Opin Infect Dis. 2021 04 01; 34(2):169-174.
Score: 0.938
-
The current status of biomarkers for the diagnosis of nosocomial pneumonias. Curr Opin Crit Care. 2017 Oct; 23(5):391-397.
Score: 0.736
-
Corticosteroid therapy for pneumonia. Lancet. 2015 Sep 05; 386(9997):954-5.
Score: 0.637
-
Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review. Clin Microbiol Infect. 2021 Jan; 27(1):47-54.
Score: 0.227
-
Do we need new trials of procalcitonin-guided antibiotic therapy? Crit Care. 2018 01 27; 22(1):17.
Score: 0.188
-
A Comparison of the Quick-SOFA and Systemic Inflammatory Response Syndrome Criteria for the Diagnosis of Sepsis and Prediction of Mortality: A Systematic Review and Meta-Analysis. Chest. 2018 03; 153(3):646-655.
Score: 0.187
-
Patterns of C-reactive protein ratio response to antibiotics in pediatric sepsis: A prospective cohort study. J Crit Care. 2018 04; 44:217-222.
Score: 0.185
-
Patterns of C-reactive protein ratio predicts outcomes in healthcare-associated pneumonia in critically ill patients with cancer. J Crit Care. 2017 12; 42:231-237.
Score: 0.181
-
Biomarker-guided antibiotic therapy-strengths and limitations. Ann Transl Med. 2017 May; 5(10):208.
Score: 0.179
-
Use of biomarkers in pediatric sepsis: literature review. Rev Bras Ter Intensiva. 2016 Oct-Dec; 28(4):472-482.
Score: 0.172
-
C-reactive protein and procalcitonin profile in ventilator-associated lower respiratory infections. J Crit Care. 2018 12; 48:385-389.
Score: 0.049
-
Impact of immunosuppression on incidence, aetiology and outcome of ventilator-associated lower respiratory tract infections. Eur Respir J. 2018 03; 51(3).
Score: 0.047